GlaxoSmithKline Pharmaceuticals reports 38% jump in Q1 net profit

07 May 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for the first quarter ended March 31, 2013

On standalone basis, the company has posted a rise of 37.53% in its net profit at Rs 169.01 crore for the quarter ended March 31, 2013 as compared to Rs 122.89 crore for the same quarter in the previous year. Total income of the company has increased marginally by 1.51% at Rs 713.84 crore for quarter under review as compared to Rs 703.19 crore for the quarter ended March 31, 2012.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxosmithkline Phar Share Price

2369.85 -28.80 (-1.20%)
13-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.80
Dr. Reddys Lab 1190.35
Cipla 1447.60
Zydus Lifesciences 900.25
Lupin 2176.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×